Endogenous mu-opioid peptides modulate immune response towards malignant melanoma
Published inExperimental dermatology, vol. 20, no. 1, p. 24-28
Publication date2011
Abstract
Keywords
- Animals
- Disease Progression
- Humans
- Lymphocytes, Tumor-Infiltrating/drug effects/immunology/pathology
- Melanoma/*immunology/metabolism/pathology
- Melanoma, Experimental/immunology/metabolism/pathology
- Mice
- Mice, Knockout
- Opioid Peptides/biosynthesis/*immunology
- Receptors, Opioid, mu/agonists/deficiency/genetics/immunology
- Skin Neoplasms/*immunology/metabolism/pathology
- Beta-Endorphin/immunology/metabolism
Affiliation Not a UNIGE publication
Citation (ISO format)
BOEHNCKE, Sandra et al. Endogenous mu-opioid peptides modulate immune response towards malignant melanoma. In: Experimental dermatology, 2011, vol. 20, n° 1, p. 24–28. doi: 10.1111/j.1600-0625.2010.01158.x
Main files (1)
Article
Identifiers
- PID : unige:29856
- DOI : 10.1111/j.1600-0625.2010.01158.x
- PMID : 20955200
ISSN of the journal0906-6705